Navigation Links
S7 with Discrete Technology Coronary Stent System

ProductsS7 with Discrete Technology Coronary Stent System
Company Medtronic Inc.
Item S7 with Discrete Technology Coronary Stent System
Features 
  • 1.0mm element length
  • Number of elements per stent has been increased 50 percent
  • The S7 delivery system features a new balloon designed specifically for the S7 stent
  • Incorporates two proven Medtronic AVE delivery technologies - Discrete Technology and Secure Technology.
Description The S7 with Discrete Technology Coronary Stent System provides enhanced deliverability plus unmatched scaffolding. Proprietary Secure Technology stent retention system features distal and proximal pillows that partially encapsulate the stent for added security during delivery. Discrete Technology is designed to minimize balloon overhang and to provide confident, precise placement in every lesion while minimizing dilatation of a healthy vessel. With shorter segments and more crowns, the S7 coronary stent offers the smallest* cell area, designed to provide excellent resistance to prolapse and to avoid gapping in bends.
Info Medtronic Inc.
Customer Service: (800) 551-5544
Web site: http://www.medtronic.com/

Related medicine products :

1. S660 with Discrete Technology Coronary Stent System
2. S670 with Discrete Technology Over-the-Wire Coronary Stent System
3. BeStent2 With Discrete Technology
4. StealthStation TRIA Surgical Navigation Technology
5. Sovereign with WhiteStar Cold Phaco Technology
6. Diamond Carpal Fusion Plates with System Pack Technology
7. StealthStation TREON plus Surgical Navigation Technology
8. synQUAD Technology
9. 3900/P Pulse Oximeter with TruTrak+ Technology
10. 3800 Pulse Oximeter with TruTrak+ Technology
11. Shandon Coverplate™ Technology
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
Medicine Products:
(Date:12/2/2008)...ers using functional MRI (fMRI) have determined th...ble for suppressing memory is dysfunctional in pat...sorders. Results of the study will be presented to...ety of North America (RSNA). , "For patients wi...ders, traumatic memories are a source of anxiety,"...
(Date:12/2/2008).... 3 Representatives from the fitne...) paid a visit to the Shriners,Hospitals for Chil...traordinary, albeit unique, cause; The Burn Machin...endly exercise equipment to the first ever Shriner... http://www.newscom.com/cgi-bin/prnh/20081203/CLW...
(Date:12/2/2008)...hers from Monash University, The Brigham and Women...anda Pharmaceuticals has found a new drug with the...s caused by shift work. , Dr Shantha Rajaratnam...ychiatry and Psychological Medicine said tasimelte...e brain, could be a highly effective treatment for...
(Date:12/2/2008)... Smile Reminder, the nation,s leadi...nveiled the latest in industry,technology today a...tal tool,for capturing and distributing video tes...ent testimonials onto popular platforms such as Yo...ool provides doctors with an effective,business s...
Breaking Medicine News(10 mins):Health News:Stress-related disorders affect brain’s processing of memory 2Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2Health News:New medication brings hope of jet lag cure 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3
...preclinical trail, that siRNA packed as a tiny sph... the University of Texas M. D. Anderson Cancer Cen...nical Cancer Research, that siRNA that are wrapped... into ovarian cancer tumour cells, which could the...
...Autism could affect the entire brain, not just the...r, and reasoning it had been once thought.// A ne... in Autism (CPEA) has shown that autism affects a ... perception, movement and memory. The researchers ...
...d that Thailand’s Public Health Ministry will enco...y to help screen patients in an attempt// to preve...h Minister Pinij Charusombat said, the blue-collar...ies instead of visiting doctors, may be left out f...
...nternational AIDS Conference in Toronto have warne... plunging into a silent epidemic of AIDS//. Only 0...rth Africa carry the virus that causes AIDS. The ...of HIV infection in the world according to UNAIDS ...
Other Medicine News:Health News:Tiny Sphere Of Nanoparticles Can Fight Cancer 2Health News:Tiny Sphere Of Nanoparticles Can Fight Cancer 3Health News:Effects Of Autism On Brain Much Wider Than Presumed 2Health News:Risk of Silent AIDS epidemic in Middle East and North Africa 2
(Date:12/1/2008)...ewswire-FirstCall/ -- Genaera Corporation (Nasdaq... has begun in study MSI-1436C-102 (Study 102), the...uemine (MSI-1436) in overweight and obese type 2 d...treatment of type 2 diabetes and obesity which wor...and leptin pathways through the highly selective i...
(Date:12/1/2008)...tCall/ -- Vical Incorporated (Nasdaq: VICL ) ann...ne payment from Merck & Co., Inc. based on Mer...l of an investigational plasmid DNA (pDNA) cancer ... DNA gene delivery technology and encodes human te...he subject of separate license agreement. , ,...
(Date:11/28/2008)...FirstCall/ -- Eli Lilly and Company,(NYSE: LLY ...ion (sNDA) from,the U.S. Food and Drug Administra...he management of chronic pain. Lilly plans to resu...dding data from a recently completed positive stud... The decision does not affect duloxetine,s FD...
(Date:11/26/2008)... , FRANKLIN, Mass., Nov. 26 /PRNewswire-First...SF) announced today that it has received full appr...DA) for its U.S. pivotal trial to study the effect...d associated therapy in the prevention of Contrast...o approved PLC,s request to expand their investiga...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Vigorous activity protects against breast cancer 28359 1Vigorous activity protects against breast cancer 28359 2The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 1The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 2The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 3The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 4The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 5The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 6The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 7The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 8The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 9Heavy Metals Can Taint Wine 28355 1Heavy Metals Can Taint Wine 28355 2Heavy Metals Can Taint Wine 28355 3Schering Plough to Appeal Jury Decision in Missouri Reimbursement Case 28353 1Schering Plough to Appeal Jury Decision in Missouri Reimbursement Case 28353 2
...re/ -- Mersana, a,cancer therapeutics company, ann...ith its lead product candidate, XMT-1001, will,be ...g of the,American Association of Cancer Research (...A. Full text of the abstracts can be,viewed online...http://www.aacr.org/">http://www.AACR.org . , The ...
...risk of cancer,returning after surgery for Kit-pos...atients receiving placebo in this trial will now b... planned for use of Glivec as,adjuvant therapy in ...tumor , * Glivec already approved as effective the...erable Kit-positive GIST , BASEL, Switzerland, Apr...
Other Medicine Technology:Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 2Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 3Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 4Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 5Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 6